- Home
- ADX vs CPRX Comparison
ADX vs CPRX Comparison
Compare ADX & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADX | CPRX |
|---|---|---|
| Founded | 1840 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | ADX | CPRX |
|---|---|---|
| Price | $22.51 | $24.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.60 |
| AVG Volume (30 Days) | 182.4K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.68% | N/A |
| EPS Growth | N/A | ★ 44.94 |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | ★ $578,196,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $7.21 |
| P/E Ratio | ★ N/A | $13.83 |
| Revenue Growth | N/A | ★ 25.56 |
| 52 Week Low | $14.94 | $19.05 |
| 52 Week High | $19.57 | $26.58 |
Technical Indicators
Market Signals| Indicator | ADX | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 65.42 |
| Support Level | $22.91 | $22.67 |
| Resistance Level | $23.33 | $23.84 |
| Average True Range (ATR) | 0.27 | 0.68 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 16.33 | 67.06 |
Price Performance
Historical ComparisonAbout ADX Adams Diversified Equity Fund Inc.
Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector neutral approach. The fund has a diversified equity portfolio which consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).